GENE WAVE

Serial Number 97049308
734

Registration Progress

Application Filed
Sep 28, 2021
Under Examination
Nov 1, 2022
Approved for Publication
Sep 6, 2022
Published for Opposition
Sep 6, 2022
Registered

Attorney Assistance

Statement of Use Due - Extension 5 Granted
Due: Nov 01, 2025 90 days
Statement of Use required (all extensions used)

Trademark Image

GENE WAVE

Basic Information

Serial Number
97049308
Filing Date
September 28, 2021
Published for Opposition
September 6, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Jun 20, 2025
Application
Pending
Classes
005

Rights Holder

Generation Bio Co.

03
Address
301 Binney Street, Suite 401
Cambridge, MA 02142

Ownership History

Generation Bio Co.

Original Applicant
03
Cambridge, MA

Generation Bio Co.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Margarita Wallach, Esq.

USPTO Deadlines

Next Deadline
90 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
November 01, 2025

Application History

32 events
Date Code Type Description Documents
Jun 21, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 20, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 1, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 1, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 31, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 31, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 31, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 31, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 1, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 30, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 30, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 30, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 30, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 30, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 30, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 3, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 1, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 1, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
May 1, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 1, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 6, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 6, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 17, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 29, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 29, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 29, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 29, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 29, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 28, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 27, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 1, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of genetic disorders and diseases; genetic medicines for the treatment of genetic diseases, related diseases having a genetic cause or component and disease states resulting from gene expression or genetic sequence

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"GENE"